Brendon Buschman
Chief Financial Officer
Brendon Buschman joined Medexus in June 2019, most recently serving as VP Finance & Corporate Controller before being appointed Chief Financial Officer in June of 2024. He has over 15 years of experience in accounting, finance and strategy with publicly traded and privately held organizations. Mr. Buschman holds a Master of Finance (MFin) from the Rotman School of Management at the University of Toronto, and a CPA, CA designation.
CFO: Chief Financial Officer in Medexus Pharmaceuticals
A Leading Innovative Specialty Pharmaceutical Company
Brendon Buschman
Chief Financial Officer